Background Spinal cord stimulation (SCS) has become a cornerstone of neuromodulatory interventions for chronic pain, offering relief where conventional ...
The FDA clears ProlivRx at-home neuromodulation for adjunctive major depressive disorder treatment in adults with inadequate antidepressant response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback